Download PDF
Erfahrungsheilkunde 2016; 65(04): 206-212
DOI: 10.1055/s-0042-109039
Praxis
© Karl F. Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Vitamin A: Retinolpalmitat

Further Information

Publication History

Publication Date:
30 August 2016 (online)

    Permissions and Reprints

Zusammenfassung

Retinolpalmitat bzw. Vitamin A gehört zu den „vergessenen“ Nährstoffen, weil es als Vitamin mit selten anzutreffendem Mangel gilt und in Therapiestudien außerhalb der Dermatologie wenig signifikante Ergebnisse erzielt wurden. In der orthomolekularen Medizin sollte Vitamin A und die therapeutisch gezielte Gabe von Retinolpalmitat wieder mehr beachtet werden. Dabei ist ein Mangel durch vegane Ernährung, Darmresorptionsstörungen und Lebererkrankungen genauso zu berücksichtigen wie eine gezielte hochdosierte redifferenzierende oder komplementäre Therapie in der Onkologie.

Abstract

Retinol or Vitamin A is one of the „forgotten“ micronutrients because it is considered a vitamin with rare deficiency and in clinical studies outside of dermatology pour results were obtained. In the good orthomolecular medicine Vitamin A and therapeutically targeted administration of retinol should be noted again more . Deficiency by veganism, bowel resorption disorders and liver disease is as to note as a specific high-dose redifferentiating or complementary therapy in oncology.

Schlüsselwörter

Vitamin A - Retinol - Haut - Krebs - orthomolekular

Keywords

Vitamin A - retinol - skin - cancer - orthomolecular
 

  • Literatur

  • 1 Berg WJ, Schwartz LH, Amsterdam A et al. A phase II study of 13-cis-retinoic acid in patients with advanced renal cell carcinoma. Invest New Drugs 1997; 15: 353-555
    CrossrefPubMedGoogle Scholar
  • 2 Ehrenpreis ED et al. Disease of the Colon and Rectum. 2005 48. 1-8
    PubMedGoogle Scholar
  • 3 Escudier B, Ravaud A, Berton D et al. Phase II study of interferon-alpha and all-trans retinoic acid in metastatic renal cell carcinoma. J Immunother 1998; 21: 62-64
    CrossrefPubMedGoogle Scholar
  • 4 Feskanich D, Singh V, Willett WC et al. Vitamin A intake and hip fractures among postmenopausal women. JAMA 2002; 287: 47-54
    CrossrefPubMedGoogle Scholar
  • 5 Formelli F, Cleris L. Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity. Cancer research 1993; 53: 5374-5376
    PubMedGoogle Scholar
  • 6 Goss GD, McBurney MW. Physiological and clinical aspects of vitamin A and its metabolites. Crit Rev Clin Lab Sci 1992; 185-215
    PubMedGoogle Scholar
  • 7 Guo X, Nanus DM, Ruiz A et al. Reduced levels of retinyl esters and vitamin A in Human Renal Cancers. Cancer Res 2001; 61: 2774-2781
    PubMedGoogle Scholar
  • 8 Hallum AV, Alberts DS, Lippman SM et al. Phase II study of 13-cis-retinoic acid plus interferon-α2a in heavily pretreated squamous carcinoma of the cervix. Gynecologic oncology 1995; 56: 382-386
    CrossrefPubMedGoogle Scholar
  • 9 Hönig-dOrville I. Retinoide in der Therapie des metastasierten Nierenzellkarzinoms: Untersuchungen am Modell multizellulärer Tumorsphäroide. Dissertation Medizinische Fakultät TH Aachen 2003.
    PubMedGoogle Scholar
  • 10 Hu F, Wu Z, Li G et al. The plasma level of retinol, vitamins A, C and α-tocopherol could reduce breast cancer risk? A meta-analysis and meta-regression. Journal of cancer research and clinical oncology 2015; 141: 601-614
    CrossrefPubMedGoogle Scholar
  • 11 Hübner J, Münstedt P, Micke O et al. Faktenblatt: Betacarotin und Vitamin A der PRIO (Prävention und Integrative Onkologie) 2015.
    PubMedGoogle Scholar
  • 12 Hunter DJ, Willett W, Blomhoff R. Vitamin A and cancer. Epidemiological evidence in humans. Vitamin A in health and disease. 1994: 561-584
    PubMedGoogle Scholar
  • 13 Issing WJ, Struck R, Naumann A et al. High concentrate A-mulsin, a new therapy concept in laryngeal leukoplakia. Laryngo-rhino-otologie 1996; 75: 29-33
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Jyothirmayi R, Ramadas K, Varghese C et al. Efficacy of vitamin A in the prevention of loco- regional recurrence and second primaries in head and neck cancer. Eur J Cancer BOral Oncol 1996; 373-376
    PubMedGoogle Scholar
  • 15 Kerscher M, Williams S. Hautalterung und Vitamine. In: Fortschritte der praktischen Dermatologie und Venerologie. Heidelberg: Springer; 2005
    CrossrefGoogle Scholar
  • 16 Kiemle-Kalle J, Porzsolt F. Retinoide in der Onkologie. Dtsch Med Wschr 1993; 390-394
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 KimJH Ki, Kim SH, He SQ et al. Use of vitamins as adjunct to conventional cancer therapy. In Nutrients in Cancer Prevention and Treatment 1995; 363-372
    PubMedGoogle Scholar
  • 18 Koletzko B, Koletzko S. Ernährung bei cystischer Fibrose. In: In: Cystische Fibrose. Heidelberg: Springer; 2001
    CrossrefGoogle Scholar
  • 19 Kucera H. Adjuvanticity of vitamin A in advanced irradiated cervical cancer. Wien Klin Wochenschr Suppl 1980; 118: 1-20
    PubMedGoogle Scholar
  • 20 Laaksorvitra S, Rajala P, Nurmi M et al. The cytostatic effect of 9-cis-retinoic acid, tretinoin, and isotretinoin on three different human bladder cell lines in vitro. Urol Res 1999; 27: 17-22
    CrossrefPubMedGoogle Scholar
  • 21 Levine N, Moon TE, Cartmel B et al. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group Cancer Epidemiol Biomarkers Prev 1997; 6: 957-961
    PubMedGoogle Scholar
  • 22 Lippmann SM, Davies PJ. Retinoids, neoplasia and differntiation therapy. Cancer Chemother Biol Response Modif 1997; 17: 349-362
    PubMedGoogle Scholar
  • 23 Lotan R. Effects of Vitamin A and its analogs (retionids) on normal and neoplastic cells. Biochim Biophys Acta 1980; 605: 33-91
    PubMedGoogle Scholar
  • 24 Meyskens FL, Kopecky KJ, Appelbaum FR. Effects of vitamin A on survival in patients with chronic myelogenous leukemia. Leuk Res 1995; 19: 605-612
    CrossrefPubMedGoogle Scholar
  • 25 Miller WH Jr. The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer. Cancer 1998; 1471-1482
    PubMedGoogle Scholar
  • 26 Mongan NP, Gudas LJ. Diverse actions of retinoid receptors in cancer prevention and treatment. Differentiation 2007; 75: 853-870
    CrossrefPubMedGoogle Scholar
  • 27 Moon TE, Levine N, Cartmel B et al. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group Cancer Epidemiol Biomarkers Prev 1997; 6: 949-56
    PubMedGoogle Scholar
  • 28 Motzer RJ, Murhy BA, Bacik J et al. Phase III trial of interferon alfa-2a with or without 13-cis retinoic acid for patients with advanced renal cell carcinoma. J Clin Oncol 2000; 18: 2972-2980
    CrossrefPubMedGoogle Scholar
  • 29 Omenn GS, Goodman GE, Thornquist MD et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New England Journal of Medicine 1996; 334: 1150-1155
    CrossrefPubMedGoogle Scholar
  • 30 De Pa, Veronesi U, Marubini E et al. Controlled clinical trials with fenretinide in breast cancer, basal cell carcinoma and oral leukoplakia. Journal of Cellular Biochemistry 1995; 59: 11-17
    PubMedGoogle Scholar
  • 31 Pastorino U, Infante M, Maioli M. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 1993; 1216-1222
    PubMedGoogle Scholar
  • 32 Plewig G, Kligman AM. Vitamin A (Retinol). Akne und Rosazea. Heidelberg: Springer; 1994
    CrossrefGoogle Scholar
  • 33 Pouchieu C, Galan P, Ducros V et al. Plasma carotenoids and retinol and overall and breast cancer risk: a nested case-control study. Nutrition and cancer 2014; 66: 980-988
    CrossrefPubMedGoogle Scholar
  • 34 Rutz HP, Little JB. Modification of radiosensitivity and recovery from X ray damage in vitro by retinoic acid. International Journal of Radiation Oncology Biology Physics 1989; 16: 1285-1288
    CrossrefPubMedGoogle Scholar
  • 35 Scheef W. Krebstherapie mit Vitamin A. In: Wrba H, (Hrsg.) Kombinierte Tumortherapie-Grundlagen, Möglichkeiten und Grenzen adjuvanter Methoden. Stuttgart: Hippokrates; 1995
    Google Scholar
  • 36 Seifter E, Rettura G, Padawer J et al. Vitamin A and beta-carotene as adjunctive therapy to tumor excision, radiation therapy, and chemotherapy. Prasad KN, (Hrsg.) Vitamins, Nutrition, and Cancer. International Symposium on Vitamins, Nutrition, and Cancer June 1983 Basel: Karger; 1984
    CrossrefGoogle Scholar
  • 37 Smith MA, Parkinson DR, Cheson BD, Friedman MA. Retinoids in cancer therapy. J Clin Oncol 1992; 10: 839-864
    CrossrefPubMedGoogle Scholar
  • 38 Snow GB, de Vries N. Zweittumoren bei Patienten mit Plattenepithelkarzinomen im Kopf-Hals-Bereich. Krebsrisiken im Kopf-Hals-Bereich 2013; 18-5
    PubMedGoogle Scholar
  • 39 Sommer A. Vitamin A. Its effect on childhood sight and life. Nutrition Reviews Washington 1994; 52: 60
    PubMedGoogle Scholar
  • 40 Struck R, Issing WJ. Einsatz von Retinolpalmitat bei Larynxleukoplakien. Sitzungsbericht Heidelberg: Springer; 1994
    CrossrefGoogle Scholar
  • 41 Vainio H, Rautalahti M. An international evaluation of the cancer preventive potential of vitamin A. Cancer Epidemiology Biomarkers and Prevention 1999; 8: 107-109
    PubMedGoogle Scholar
  • 42 Veronesi U, De Palo G, Marubini E et al. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. Journal of the National Cancer Institute 1999; 91: 1847-1856
    CrossrefPubMedGoogle Scholar
  • 43 Warrell RP Jr., Frankel SR, Miller WH et al. Differentiation therapy of acute promyelotic leukemia with tretinoin (all-trans-retionoic acid). N Engl J Med 1991; 324: 1385-1393
    CrossrefPubMedGoogle Scholar
  • 44 van Zandwijk N, Dalesio O, Pastorino U et al. EUROSCAN, a randomized Trial of Vitamin A and N-Acetylcysteine in patient with head and neck cancer or lung cancer. Journal of the National Cancer Institut 2000; 92: 977-986
    PubMedGoogle Scholar
  • 45 Zaridze D, Evstifeeva T, Boyle P. Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer. Annals of epidemiology 1993; 3: 225-234
    CrossrefPubMedGoogle Scholar